Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

CVRx, Inc. (CVRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/25/2023 8-K Quarterly results
06/08/2023 8-K Investor presentation
Docs: "2 Cautionary Note Regarding Forward-Looking Statement This presentation by CVRx, Inc. contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including statements regarding our future financial performance , our anticipated growth strategies, anticipated trends in our industry, our business prospects and our opportunities. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “outlook,” “guidance,” “intend,” “target,..."
04/27/2023 8-K Quarterly results
03/21/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Totality of Evidence from BeAT-HF Study Shows CVRx’ s Barostim Provides Long-term Benefits for Patients with Heart Failure",
"Presentation of CVRx, Inc."
03/15/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ...
01/26/2023 8-K Quarterly results
Docs: "CVRx, INC. Condensed Consolidated Balance Sheets December 31, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 106,194 $ 142,072 Accounts receivable, net of allowances of $679 and $0, respectively 5,504 2,560 Inventory 6,957 3,880 Prepaid expenses and other current assets 4,223 2,585 Total current assets 122,878 151,097 Property and equipment, net 1,698 1,425 Operating lease right-of-use asset 334 — Other non-current assets 27 26 Total assets $ 124,937 $ 152,548 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 1,719 $ 510 Accrued expenses 6,369 5,398 Total current liabilities 8,088 5,908 Long-term debt 6,747 — Operating lease liability, non-current portion 117 — Other long-term liabilities 805 681 Total liabilities 15,757 6,589 Commitme..."
01/09/2023 8-K Quarterly results
12/20/2022 8-K Quarterly results
11/01/2022 8-K Quarterly results
Docs: "Loan and Security Agreement, among CVRx, Inc., Innovatus Life Sciences Fund I, LP, as the collateral agent and a lender, and the other lenders from time to time party thereto",
"CVRx, INC. Condensed Consolidated Balance Sheets September 30, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 109,985 $ 142,072 Accounts receivable, net 5,297 2,560 Inventory 6,064 3,880 Prepaid expenses and other current assets 3,066 2,585 Total current assets 124,412 151,097 Property and equipment, net 1,747 1,425 Operating lease right-of-use asset 391 — Other non-current assets 26 26 Total assets $ 126,576 $ 152,548 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 1,276 $ 510 Accrued expenses 6,120 5,398 Total current liabilities 7,396 5,908 Operating lease liability, non-current portion 175 — Other long-term liabilities 761 681 Total liabilities 8,332 6,589 Commitments and contingencies Stockholders’ equity: Common stock, $0.01 pa..."
07/28/2022 8-K Quarterly results
06/09/2022 8-K Quarterly results
04/25/2022 8-K Quarterly results
Docs: "CVRx, INC. Condensed Consolidated Balance Sheets March 31, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 131,177 $ 142,072 Accounts receivable, net 3,673 2,560 Inventory 5,261 3,880 Prepaid expenses and other current assets 2,090 2,585 Total current assets 142,201 151,097 Property and equipment, net 1,656 1,425 Operating lease right-of-use asset 522 — Other non-current assets 26 26 Total assets $ 144,405 $ 152,548 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 1,607 $ 510 Accrued expenses 4,985 5,398 Total current liabilities 6,592 5,908 Operating lease liability, non-current portion 304 — Other long-term liabilities 706 681 Total liabilities 7,602 6,589 Commitments and contingencies Stockholders’ equity : Common stock, $0.01 par v..."
02/15/2022 8-K Quarterly results
Docs: "CVRx, INC. Consolidated Balance Sheets December 31, December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 142,072 $ 59,112 Accounts receivable, net 2,560 1,281 Inventory 3,880 3,343 Prepaid expenses and other current assets 2,585 605 Total current assets 151,097 64,341 Property and equipment, net 1,425 410 Other non-current assets 26 26 Total assets $ 152,548 $ 64,777 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 510 $ 483 Accrued expenses 5,398 3,583 Warrant liability — 3,911 Total current liabilities 5,908 7,977 Long-term debt — 19,278 Other long-term liabilities 681 777 Total liabilities 6,589 28,032 Commitments and contingencies Convertible preferred stock, $0.01 par value, 10,000,000 and 237,370,645 authorized as of December 31, 2021..."
01/10/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "[email protected]"
11/04/2021 8-K Quarterly results
Docs: "CVRx, INC. Condensed Consolidated Balance Sheets September 30, December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 170,913 $ 59,112 Accounts receivable, net 3,421 1,281 Inventory 3,440 3,343 Prepaid expenses and other current assets 2,923 605 Total current assets 180,697 64,341 Property and equipment, net 943 410 Other non-current assets 67 26 Total assets $ 181,707 $ 64,777 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 541 $ 483 Accrued expenses 4,977 3,583 Warrant liability — 3,911 Current portion of long-term debt 3,333 — Total current liabilities 8,851 7,977 Long-term debt 16,151 19,278 Other long-term liabilities 941 777 Total liabilities 25,943 28,032 Commitments and contingencies Convertible preferred stock, $0.01 par value, 10,0..."
08/04/2021 8-K Quarterly results
Docs: "CVRx Reports Second Quarter 2021 Financial and Operating Results"
07/12/2021 8-K Quarterly results
07/07/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
Docs: "Amended and Restated Certificate of Incorporation of CVRx, Inc",
"Amended and Restated By-Laws of CVRx, Inc"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy